发明公开
EP1945197A1 STABILIZED EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A BETA-ADRENORECEPTOR ANTAGONIST 审中-公开
来稳定的β阻断拮抗剂缓释药物组合物的

  • 专利标题: STABILIZED EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A BETA-ADRENORECEPTOR ANTAGONIST
  • 专利标题(中): 来稳定的β阻断拮抗剂缓释药物组合物的
  • 申请号: EP06790888.9
    申请日: 2006-10-24
  • 公开(公告)号: EP1945197A1
    公开(公告)日: 2008-07-23
  • 发明人: JOSHI, LaxminarayanLEFLER, Robert, Scott
  • 申请人: Orbus Pharma Inc.
  • 申请人地址: 20 Konrad Crescent Markham, ON L3R 8T4 CA
  • 专利权人: Orbus Pharma Inc.
  • 当前专利权人: Orbus Pharma Inc.
  • 当前专利权人地址: 20 Konrad Crescent Markham, ON L3R 8T4 CA
  • 代理机构: Vogel, Andreas
  • 优先权: US257526 20051024; US551865 20061023
  • 国际公布: WO2007048233 20070503
  • 主分类号: A61K31/138
  • IPC分类号: A61K31/138 A61K47/30 A61K9/28
STABILIZED EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A BETA-ADRENORECEPTOR ANTAGONIST
摘要:
The present invention is a new stable extended release drug composition particularly suitable for use as a beta-adrenoreceptor antagonist agent. The present invention is specifically a drug composition comprising a pharmaceutical, a methacrylic acid copolymer and a matrix forming agent, and a method for manufacturing same. When applied to highly soluble drugs like metoprolol succinate, the resulting drug composition is characterized by an extended-release profile.
信息查询
0/0